| 注册
首页|期刊导航|中国药房|我院2009年2月-2010年2月107例患者应用尼妥珠单抗分析

我院2009年2月-2010年2月107例患者应用尼妥珠单抗分析

方青芳 裘友好 方罗 叶晓春 林能明

中国药房2011,Vol.22Issue(22):2039-2041,3.
中国药房2011,Vol.22Issue(22):2039-2041,3.

我院2009年2月-2010年2月107例患者应用尼妥珠单抗分析

Analysis of the Application of Nimotuzumab in 107 Patients of Our Hospital during Feb.2009-Feb.2010

方青芳 1裘友好 2方罗 1叶晓春 1林能明1

作者信息

  • 1. 浙江省肿瘤医院药剂科,杭州市,310022
  • 2. 浙江省肿瘤医院中西医结合科,杭州市,310022
  • 折叠

摘要

Abstract

OBJECTIVE: To investigate the application, therapeutic efficacy and adverse drug reaction of nimotuzumab in our hospital. METHODS: Clinical information of patients who were treated with nimotuzumab was collected from our hospital during Feb. 2009-Feb. 2010. The clinical diagnosis and the conformance of drug use to package inserts were analyzed. The therapeutic efficacy and safety of drug use were evaluated. RESULTS: The conformance rate of drug use to the indications of package inserts was 69.2%, and the conformance rate of drug use to indications stated in foreign literatures was 12.2%. 18.7% of nimotuzumab use was beyond indications of package insert and domestic and foreign literatures. CONCLUSION: Nimotuzumab combined with radiotherapy is helpful for clinical treatment with mild adverse drug reactions. The application of nimotuzumab beyond the indications of package inserts is widespread, which is up to evidence-base medicine and the spirit of ethics, but not fit to legal norms. Thus, pharmaceutical care needs to be strengthened.

关键词

尼妥珠单抗/临床应用/分析

Key words

Nimotuzumab/ Clinical application/ Analysis

分类

医药卫生

引用本文复制引用

方青芳,裘友好,方罗,叶晓春,林能明..我院2009年2月-2010年2月107例患者应用尼妥珠单抗分析[J].中国药房,2011,22(22):2039-2041,3.

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文